Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_provenance.
- NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_assertion description "[In vitro assessment of targeting by the CNGRC/PEG/PEI/DNA vector carrying a beta-galactosidase (beta-Gal)-expressing plasmid showed as much as a 5-fold increase in transduction, relative to the untargeted PEG/PEI/DNA-betagal vector, of CD13-positive lung cancer, fibrosarcoma, bladder cancer, and human umbilical vein endothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_provenance.
- NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_assertion evidence source_evidence_literature NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_provenance.
- NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_assertion SIO_000772 15703489 NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_provenance.
- NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_assertion wasDerivedFrom befree-20140225 NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_provenance.
- NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_assertion wasGeneratedBy ECO_0000203 NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP628502.RAIBHvv7gRHSH2Nwb2BRQrvg2j35pja1-D0LaxegdiAu4130_provenance.